DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
KRRO Korro Bio
- 43.750
- -0.710-1.60%
Trading Dec 19 12:36 ET
409.86MMarket Cap-4.32P/E (TTM)
48.458High43.060Low46.19KVolume45.170Open44.460Pre Close2.03MTurnover1.04%Turnover RatioLossP/E (Static)9.37MShares98.00052wk High2.28P/B194.14MFloat Cap30.00552wk Low--Dividend TTM4.44MShs Float2918.500Historical High--Div YieldTTM12.14%Amplitude9.150Historical Low43.965Avg Price1Lot Size
Korro Bio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -36.72%-16.1M | 0.83%-14.59M | -11.18%-21.89M | -25.42%-67.28M | -21.11M | -11.77M | -14.72M | -19.69M | -67.15%-53.65M | -32.09M |
| Net income from continuing operations | -13.56%-21M | -23.67%-21.83M | 0.24%-19.56M | -39.87%-81.17M | ---25.43M | ---18.49M | ---17.65M | ---19.61M | -164.27%-58.03M | ---21.96M |
| Operating gains losses | ---- | ---- | ---- | --65K | ---- | ---- | ---- | ---- | ---- | --8K |
| Depreciation and amortization | -5.88%865K | -21.37%721K | -10.26%726K | 44.56%3.63M | --985K | --919K | --917K | --809K | 57.43%2.51M | --1.6M |
| Other non cash items | -22.76%818K | 25.42%1.11M | 178.47%1.2M | 138.44%3.61M | --1.23M | --1.06M | --885K | --432K | 111.24%1.51M | ---13.47M |
| Change In working capital | -32.33%2.94M | 520.75%4.61M | -219.30%-5.13M | 776.62%4.28M | --808K | --4.34M | --742K | ---1.61M | -170.02%-633K | --904K |
| -Change in prepaid assets | 487.06%499K | -555.37%-1.1M | 14.96%-290K | 2,096.43%559K | --573K | --85K | --242K | ---341K | 92.96%-28K | ---398K |
| -Change in payables and accrued expense | -149.40%-945K | 343.37%3.08M | -1,243.84%-7.63M | 154.66%4.37M | --2.33M | --1.91M | --694K | ---568K | -14.92%1.72M | --2.02M |
| -Change in other current assets | -53.23%58K | 473.33%86K | 4,400.00%86K | -1,515.45%-1.99M | ---2.12M | --124K | --15K | ---2K | -324.14%-123K | ---29K |
| -Change in other current liabilities | 49.93%3.32M | 1,317.70%2.55M | 489.78%2.71M | 161.01%1.34M | --28K | --2.22M | ---209K | ---695K | ---2.2M | --0 |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---686K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -36.72%-16.1M | 0.83%-14.59M | -11.18%-21.89M | -25.42%-67.28M | ---21.11M | ---11.77M | ---14.72M | ---19.69M | -67.15%-53.65M | ---32.09M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,768.17%-12.58M | -2,892.20%-102.39M | -136.23%-5.61M | 0.94%11.16M | -1.66M | 754K | -3.42M | 15.49M | 128.00%11.06M | -39.5M |
| Net PPE purchase and sale | -1,882.93%-4.88M | -34.80%-5.96M | -270.85%-5.61M | -50.35%-7.84M | ---1.66M | ---246K | ---4.42M | ---1.51M | -17.55%-5.21M | ---4.43M |
| Net investment purchase and sale | -870.00%-7.7M | -9,743.20%-96.43M | --0 | 16.76%19M | --0 | --1M | --1M | --17M | 146.40%16.27M | ---35.07M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,768.17%-12.58M | -2,892.20%-102.39M | -136.23%-5.61M | 0.94%11.16M | ---1.66M | --754K | ---3.42M | --15.49M | 128.00%11.06M | ---39.5M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 133.21%728K | 187,755.56%67.56M | -99.69%139K | 1,043,016.67%187.76M | 144.59M | -2.19M | -36K | 45.4M | -99.98%18K | 115.95M |
| Net common stock issuance | --0 | ---- | ---- | --117.25M | --117.25M | --0 | ---- | ---- | --0 | ---- |
| Net preferred stock issuance | --0 | --0 | --0 | --45.46M | --0 | --0 | ---42K | --45.5M | --0 | --115.95M |
| Proceeds from stock option exercised by employees | 237.04%728K | 109.76%172K | 172.55%139K | 1,032.26%702K | --353K | --216K | --82K | --51K | 121.43%62K | --28K |
| Net other financing activities | ---- | ---- | ---- | 55,443.18%24.35M | --26.99M | ---2.41M | ---76K | ---150K | -46.67%-44K | ---30K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 133.21%728K | 187,755.56%67.56M | -99.69%139K | 1,043,016.67%187.76M | --144.59M | ---2.19M | ---36K | --45.4M | -99.98%18K | --115.95M |
| Net cash flow | ||||||||||
| Beginning cash position | 49.34%96.33M | 76.30%145.76M | 317.39%173.12M | -50.65%41.48M | --51.29M | --64.5M | --82.68M | --41.48M | 111.73%84.04M | --39.69M |
| Current changes in cash | -111.56%-27.95M | -172.00%-49.43M | -166.42%-27.36M | 409.26%131.64M | --121.83M | ---13.21M | ---18.17M | --41.2M | -195.98%-42.57M | --44.35M |
| End cash Position | 33.31%68.38M | 49.34%96.33M | 76.30%145.76M | 317.39%173.12M | --173.12M | --51.29M | --64.5M | --82.68M | -50.65%41.48M | --84.04M |
| Free cash flow | -74.51%-20.97M | -7.40%-20.55M | -29.71%-27.5M | -27.63%-75.12M | ---22.76M | ---12.02M | ---19.14M | ---21.2M | -61.07%-58.86M | ---36.54M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |